These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4479624)

  • 21. I/i antigens on the peripheral blood lymphocytes in Graves disease.
    Pruzanski W; Volpe R; Armstrong M
    Cell Immunol; 1979 Jun; 45(1):237-40. PubMed ID: 582297
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of autoimmunity in Graves' disease before and after treatment with carbimazole.
    Zosin I; Arcan P; Lungu G; Cotoi A; Opreanu R
    Endocrinologie; 1988; 26(1):49-53. PubMed ID: 3260398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA control of thyroglobulin-induced blast-transformation in Graves' disease.
    Stenszky V; Balás C; Kozma L; Leövey A; Farid NR
    Hum Hered; 1981; 31(5):322-4. PubMed ID: 6949858
    [No Abstract]   [Full Text] [Related]  

  • 24. Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy.
    Blau HM; Kaplan I; Tao TW; Kriss JP
    Life Sci; 1983 Jan 3-10; 32(1-2):45-53. PubMed ID: 6687485
    [No Abstract]   [Full Text] [Related]  

  • 25. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
    Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
    J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
    Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
    [No Abstract]   [Full Text] [Related]  

  • 27. Demonstration of circulating immune complexes in Graves' disease by the Raji cell technique and their relation to different thyroid autoantibodies.
    Hopf U; Hütteroth TH; Kotulla P
    Horm Metab Res; 1979 Nov; 11(11):622-8. PubMed ID: 231561
    [No Abstract]   [Full Text] [Related]  

  • 28. HL-A typing in Asian Indians.
    Singal DP; Mickey MR; Terasaki PI
    Tissue Antigens; 1971; 1(6):286-9. PubMed ID: 5154533
    [No Abstract]   [Full Text] [Related]  

  • 29. An investigation of pedigrees of 110 patients with Graves' disease and the clinical significance of determinations of antithyroid antibodies of their first-degree relatives.
    Wang DQ; Wang JZ; Ren JM; Zhou XT; Peng WC
    Chin Med J (Engl); 1994 Nov; 107(11):817-21. PubMed ID: 7867387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroglobulin antibodies in Graves' disease are associated with T-cell receptor beta chain and major histocompatibility complex loci.
    Demaine AG; Ratanachaiyavong S; Pope R; Ewins D; Millward BA; McGregor AM
    Clin Exp Immunol; 1989 Jul; 77(1):21-4. PubMed ID: 2569950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of some of the HL-A system lymphocyte antigens in Mexicans. I. Mestizo and Mexican Indian population.
    Gorodezky C; Escobar-Gutiérrez A; Salazar-Mallén M
    Vox Sang; 1972; 23(5):439-43. PubMed ID: 4672921
    [No Abstract]   [Full Text] [Related]  

  • 32. [Personal experience in the study of thyroid autoimmunity and endocrine exophthalmos].
    Winand R
    Bull Mem Acad R Med Belg; 1989; 144(5-7):363-70; discussion 370-2. PubMed ID: 2575920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HL-A polymorphism of Norwegian Lapps.
    Thorsby E; Bratlie A; Teisberg P
    Tissue Antigens; 1971; 1(3):137-46. PubMed ID: 4116443
    [No Abstract]   [Full Text] [Related]  

  • 34. Triiodothyronine autoantibodies in Graves' disease: their changes after antithyroid therapy and relationship with the thyroglobulin antibodies.
    Wang PW; Huang MJ; Liu RT; Chen CD
    Acta Endocrinol (Copenh); 1990 Jan; 122(1):22-8. PubMed ID: 1689529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Mo 91 antigen, an allele at the first HL-A locus.
    Seignalet J
    Tissue Antigens; 1972; 2(6):454-60. PubMed ID: 4119292
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunological parameters in Graves' disease: are they useful for indication and monitoring of antithyroid drug treatment?
    Orgiazzi J; Madec AM; Genetet N; Gueguen M; Allannic H
    Horm Res; 1987; 26(1-4):131-6. PubMed ID: 2439426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathogenesis of Graves' disease.
    Gossage AA; Munro DS
    Clin Endocrinol Metab; 1985 May; 14(2):299-330. PubMed ID: 2866051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subpopulations of intrathyroidal lymphocytes in Graves' disease.
    Duh YC; Su IJ; Liaw KY; Yao CC
    J Formos Med Assoc; 1990 Feb; 89(2):121-5. PubMed ID: 1973719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy.
    Faryna M; Nauman J; Gardas A
    Br Med J (Clin Res Ed); 1985 Jan; 290(6463):191-2. PubMed ID: 3917747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibodies against thyroid microsomes and thyroglobulin in Basedow's disease and other diseases].
    Scherbaum WA; Rosenau KO; Seif FJ
    Med Welt; 1979 Sep; 30(38):1401-6. PubMed ID: 384139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.